Phil Grinnell - Natera VP Sales
| NTRA Stock | USD 91.66 0.38 0.42% |
Insider
Phil Grinnell is VP Sales of Natera Inc
| Address | 13011 McCallen Pass, Austin, TX, United States, 78753 |
| Phone | 650 980 9190 |
| Web | https://www.natera.com |
Natera Management Efficiency
The company has return on total asset (ROA) of (0.1967) % which means that it has lost $0.1967 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5911) %, meaning that it created substantial loss on money invested by shareholders. Natera's management efficiency ratios could be used to measure how well Natera manages its routine affairs as well as how well it operates its assets and liabilities. As of April 27, 2024, Return On Tangible Assets is expected to decline to -0.31. In addition to that, Return On Capital Employed is expected to decline to -0.41. At present, Natera's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 208.5 M, whereas Other Assets are forecasted to decline to about 11.3 M.Similar Executives
| Showing other executives | INSIDER Age | ||
| Carissa Rollins | Illumina | 54 | |
| Sandy Pound | Thermo Fisher Scientific | N/A | |
| Jessica Mega | Danaher | 46 | |
| Erin Smith | Twist Bioscience Corp | N/A | |
| JoseCarlos GutierrezRamos | Danaher | 62 | |
| Mikael Dolsten | Agilent Technologies | 62 | |
| Syed Jafry | Thermo Fisher Scientific | 56 | |
| Nicole Lambert | Myriad Genetics | 50 | |
| Kevin Pegels | Illumina | 56 | |
| Alexander MD | Illumina | 47 | |
| Scott Ericksen | Illumina | 51 | |
| Siyuan Chen | Twist Bioscience Corp | N/A | |
| Otis Brawley | Agilent Technologies | 61 | |
| Kevin Yankton | Twist Bioscience Corp | 57 | |
| Pardis Sabeti | Danaher | 45 | |
| Natalie Munk | Myriad Genetics | 43 | |
| Gianluca Pettiti | Thermo Fisher Scientific | 45 | |
| Clivetty Martinez | Myriad Genetics | N/A | |
| Ruby Chandy | Thermo Fisher Scientific | 58 | |
| Aaron Sato | Twist Bioscience Corp | N/A | |
| Padraig McDonnell | Agilent Technologies | 49 | |
Management Performance
| Return On Equity | -0.59 | ||||
| Return On Asset | -0.2 |
Natera Inc Leadership Team
Elected by the shareholders, the Natera's board of directors comprises two types of representatives: Natera inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Natera. The board's role is to monitor Natera's management team and ensure that shareholders' interests are well served. Natera's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Natera's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Steve Chapman, Senior Vice President - Commercial Operations | ||
| Michael MBA, Chief Officer | ||
| Margaret Miller, Vice President - Finance | ||
| Paul Billings, Chief Medical Officer and Senior Vice-President of Medical Affairs | ||
| Jonathan MEng, CoFounder Director | ||
| John Fesko, President Officer | ||
| Roy Baynes, Director | ||
| Robert Schueren, Chief Officer | ||
| Edward Driscoll, Director | ||
| Daniel LLM, Secretary Officer | ||
| Michael Little, Senior Vice President - Research and Development | ||
| Michael Brophy, CFO | ||
| Jerry Diffley, Chief Officer | ||
| John Steuart, Director | ||
| James Healy, Director | ||
| Jonathan Sheena, Co-Founder, CTO, Director | ||
| Roelof Botha, Lead Independent Director | ||
| Olesya CPA, Chief Officer | ||
| Gail Marcus, Independent Director | ||
| LLM LLM, S Officer | ||
| Rishi Kacker, Chief Officer | ||
| Phil Grinnell, VP Sales | ||
| Steven Chapman, CEO Director | ||
| Todd Cozzens, Director | ||
| Eric Evans, Chief Officer | ||
| Herman Rosenman, CFO | ||
| Matthew Rabinowitz, Co-Founder, Chairman, CEO and Pres |
Natera Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Natera a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.59 | ||||
| Return On Asset | -0.2 | ||||
| Profit Margin | (0.40) % | ||||
| Operating Margin | (0.27) % | ||||
| Current Valuation | 10.61 B | ||||
| Shares Outstanding | 120.76 M | ||||
| Shares Owned By Insiders | 4.03 % | ||||
| Shares Owned By Institutions | 96.31 % | ||||
| Number Of Shares Shorted | 5.76 M | ||||
| Price To Earning | (4.74) X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Natera Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Natera Stock analysis
When running Natera's price analysis, check to measure Natera's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Natera is operating at the current time. Most of Natera's value examination focuses on studying past and present price action to predict the probability of Natera's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Natera's price. Additionally, you may evaluate how the addition of Natera to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Transaction History View history of all your transactions and understand their impact on performance |
Is Natera's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Natera. If investors know Natera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Natera listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.78) | Revenue Per Share 9.414 | Quarterly Revenue Growth 0.432 | Return On Assets (0.20) | Return On Equity (0.59) |
The market value of Natera Inc is measured differently than its book value, which is the value of Natera that is recorded on the company's balance sheet. Investors also form their own opinion of Natera's value that differs from its market value or its book value, called intrinsic value, which is Natera's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Natera's market value can be influenced by many factors that don't directly affect Natera's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Natera's value and its price as these two are different measures arrived at by different means. Investors typically determine if Natera is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Natera's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.